Mayo Clinic of Arizona

Phoenix, Arizona 85054

0 studies enrolling now · 3 studies all time

What they study most

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Fallopian Tube Cancer, Gallbladder Adenocarcinoma, Multiple Myeloma, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Ductal Adenocarcinoma, Primary Biliary Cirrhosis (PBC), Triple Negative Breast Cancer

Studies at this site

• Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC) — Stopped early
• A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers — Stopped early
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early